Entering text into the input field will update the search result below

Many Alzheimer's drug developers close significantly higher thanks to Biogen, Eisai data

Neuron system disease

koto_feja

Biogen (NASDAQ:BIIB) and Eisai (OTCPK:ESALY) weren't the only drug companies developing Alzheimer's treatments that finished Wednesday significantly higher.

The duo closed up, respectively, 40% and ~58% higher following Tuesday's after the market close release of phase 3 data

Recommended For You

Related Stocks

SymbolLast Price% Chg
BIIB
--
ESALY
--